| Literature DB >> 36157742 |
Aykut Arif Topçu1, Seçkin Kılıç2, Erdoğan Özgür2, Deniz Türkmen2, Adil Denizli2.
Abstract
Affinity chromatography is a well-known method dependent on molecular recognition and is used to purify biomolecules by mimicking the specific interactions between the biomolecules and their substrates. Enzyme substrates, cofactors, antigens, and inhibitors are generally utilized as bioligands in affinity chromatography. However, their cost, instability, and leakage problems are the main drawbacks of these bioligands. Biomimetic affinity ligands can recognize their target molecules with high selectivity. Their cost-effectiveness and chemical and biological stabilities make these antibody analogs favorable candidates for affinity chromatography applications. Biomimetics applies to nature and aims to develop nanodevices, processes, and nanomaterials. Today, biomimetics provides a design approach to the biomimetic affinity ligands with the aid of computational methods, rational design, and other approaches to meet the requirements of the bioligands and improve the downstream process. This review highlighted the recent trends in designing biomimetic affinity ligands and summarized their binding interactions with the target molecules with computational approaches.Entities:
Year: 2022 PMID: 36157742 PMCID: PMC9494661 DOI: 10.1021/acsomega.2c03530
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Schematic diagram of affinity chromatography: (a) loading, (b) capture of a target molecule, and (c) elution of the target molecule.
Figure 2Schematic representation of MIPs.
Figure 3(a) Structure of functional monomers and (b) schematic representation of MIP against SARS-CoV-2. Reprinted with the permission from ref (26). Copyright 2021 Elsevier B.V.
Figure 4Molecular electrostatic potential (MEP) of the target molecule, MYC, and the functional monomers. Reprinted with permisson from ref (28). Copyright 2021 Elsevier.
Other Applications of MIPs use Computational Approachesa
| functional monomer | template | cross-linker | solvent | ref |
|---|---|---|---|---|
| trifluoromethacrylic acid | norfloxacin | TRIM | toluene | ( |
| pyrrole | closental | – | ethanol | ( |
| APTES | bisphenol A | EGDMA | acetonitrile | ( |
| methacrylamide | bilobalide | TMPTA | acetonitrile | ( |
| 4-VP and methaacryclic acid | acetaminophen | – | tetrahydrofuran | ( |
| methacrylamide | ginkgolide B | EGDMA | acetonitrile | ( |
| pABA- | tetradifon | – | water and acetonitrile | ( |
| acylamide | deltamethin | EGDMA | ( | |
| para amino benzoic acid | diosgenin | – | phosphate buffer | ( |
| thiosermibarbazone monomers | catechin | EGDMA | acetone/acetonitrile | ( |
| arginine | theophylline | – | ( | |
| acrylic acid | buprenorphine | EGDMA | DMSO | ( |
| methacrylic acid | norfloxacin | EGDMA | DMSO | ( |
| itaconic acid | nevothroxine | EGDMA | ( | |
| methylacrylamide | eactopamine | – | DMSO | ( |
| methacrylic acid | levetiraetam | EGDMA | chloroform | ( |
| methacrylic acid or 2- (trifluoro methacrylic acid) | atrazine | – | toluene | ( |
| M-phenylenediamine | immunoglobulin G | DTPPS | ethanol | ( |
| methacylamide | morphine | EGDMA | water | ( |
| APTES | sulfamethoxazole | TEOS | ethanol | ( |
| methacrylic acid | celecoxib | EGDMA | acetonitrile | ( |
| methacrylic acid | phenol | EGDMA | toluene | ( |
Abbreviations: APTES (3-aminopropyltriethoxysilane); 4-VP (4-vinylpyridine); pABA-co-DDS (para amino benzoic acid and 4,4-diaminodiphenyl sulfone); TRIM (trihydroxymethylpropyl trimethyl acrylate); TMPTA (trimethylolpropane triacrylate), DMSO (dimethyl sulfoxide), DTSSP (3,3′-dithiobis (sulfosuccinimidylpropionate), and TEOS (tetraethyl orthosilicate).
Figure 5A, B, C, and D represent the six conformations of CB with HSA. Reprinted with the permission from ref (53). Copyright 2021 Elsevier.
Summary of the Biomimetic Dye Ligands and the Design of Triazine Scaffolds Using Computational Methods and Their Affinity Chromatography Applications
| dye or ligand | target molecule | purpose | method | ref |
|---|---|---|---|---|
| triazine dye | glutamate oxidase | purification | bioinformatic analysis | ( |
| ligand 22/8 | human immunoglobulin G (IgG) | purification | molecular modeling | ( |
| red HE-3B | lactoferrin | analysis of the dye and protein binding sites | molecular modeling | ( |
| cibacron blue 3GA | antibody 2G12 | purification | molecular modeling and molecular dynamics simulation | ( |
| galactosyl-mimo dye ligands | galactose dehydrogenase | purification | molecular modeling and ligand docking | ( |
| rhodamine B | human serum albumin | analysis of interaction of dye and protein | molecular modeling and molecular dynamic simulations | ( |
| azo dye (amaranth) | bovine serum albumin | analysis of interaction of dye and protein | molecular docking studies | ( |
| allura red AC | human serum albumin | analysis of binding interaction dye and protein | molecular modeling | ( |
| azo dyes | lysozyme | analysis of molecular reaction of dye and protein | molecular modeling | ( |
| C.I. acid red 88 | serum albumins | analysis of binding behavior of dye and proteins | molecular modelingMD | ( |
Figure 6(a) Characterization of aptamers, (b) 2D structures prediction of aptamers with the aid of the mfold and 3dRNA-V2.0 online tools, and (c) binding modes of aptamers and ZEN molecule via molecular docking. Reprinted from ref (73). Copyright 2018 ACS.
Some of the Aptamers and Their Applications
| aptamer | target | method | purpose | ref |
|---|---|---|---|---|
| APTSTX-1 | saxitocin | molecular dynamics | sensing | ( |
| Z3IN | zearalenone | computational docking simulation | sensing | ( |
| P-30 | patulin | molecular docking and circular dichroism | detection | ( |
| AOT1 conjugated gold nanoparticles | oxytetracycline | molecular docking and circular dichroism spectroscopy | detection | ( |
| MAptapro-IR1 | SARS-CoV-2 Mpro enzyme | molecular docking and molecular dynamic simulation | to develop a therapeutic drug for the COVID-19 disease | ( |
| the conjugation of aptamer and single-walled carbon nanotubes | prostate-specific antigen (PSA) | molecular dynamic simulations | to understand the interaction mechanism and design an aptasensor | ( |
| Tro4apt | cardiac troponin I | docking and molecular dynamics | screening and sensor development | ( |
| F20 | aflatoxin B1 | combination of | sensing | ( |
| AT11 | nucleolin | to investigate the activity of the aptamer toward the target | ( | |
| FLC112 | angiotensin II | mocking simulation | to investigate the interactions of the aptamer and the target | ( |
| DF20 | diazinon | docking and molecular dynamic simulation | sensing | ( |
| 51A1 | cytochrome p450 | molecular docking and molecular dynamics | to design the aptamer | ( |
| RNA aptamer | flavin | molecular dynamics simulations | to design the sensor | ( |
| P-18S2 | palytoxin | molecular docking and molecular dynamic simulations | to understand the binding mechanism of the aptamer and the target | ( |
| RBA | retinol binding protein 4 | molecular dynamics simulations | to understand the binding mechanism of the aptamer and the target | ( |
| RNA aptamer | cell surface
protein of | molecular docking | to design and optimize the aptamer | ( |
| WGQWPYHC | targeting translationally controlled tumor protein (TCTP) | molecular docking studies and bioinformatics | to investigate the interactions between the aptamer and the protein | ( |